LLPH expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.358800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
8.947200E-01
Normal-vs-Stage2
9.305800E-01
Normal-vs-Stage3
7.238000E-01
Normal-vs-Stage4
5.055200E-01
Stage1-vs-Stage2
9.564000E-01
Stage1-vs-Stage3
7.503400E-01
Stage1-vs-Stage4
4.641200E-01
Stage2-vs-Stage3
6.364800E-01
Stage2-vs-Stage4
4.693800E-01
Stage3-vs-Stage4
4.283000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.697000E-01
Normal-vs-AfricanAmerican
8.964000E-01
Normal-vs-Asian
3.018200E-01
Caucasian-vs-AfricanAmerican
9.102200E-01
Caucasian-vs-Asian
1.254750E-01
AfricanAmerican-vs-Asian
2.908000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.729600E-01
Normal-vs-Female
8.233800E-01
Male-vs-Female
3.244800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.448200E-01
Normal-vs-Age(41-60Yrs)
6.720200E-01
Normal-vs-Age(61-80Yrs)
7.543400E-01
Normal-vs-Age(81-100Yrs)
9.071400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.666580E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
5.280200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.780400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.074330E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
3.278600E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.540400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.537600E-01
Normal-vs-Daily Drinker
6.568000E-01
Normal-vs-Weekly Drinker
8.483200E-01
Normal-vs-Occasional Drinker
6.537000E-01
Normal-vs-Social Drinker
7.597400E-01
Non Drinker-vs-Daily Drinker
4.398400E-01
Non Drinker-vs-Weekly Drinker
2.998000E-01
Non Drinker-vs-Occasional Drinker
1.016310E-02
Non Drinker-vs-Social Drinker
1.830650E-01
Daily Drinker-vs-Weekly Drinker
7.285600E-01
Daily Drinker-vs-Occasional Drinker
9.631700E-02
Daily Drinker-vs-Social Drinker
6.423600E-01
Weekly Drinker-vs-Occasional Drinker
2.865600E-01
Weekly Drinker-vs-Social Drinker
9.782200E-01
Occasional Drinker-vs-Social Drinker
1.824350E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
8.620800E-01
Normal-vs-Grade 2
7.515400E-01
Normal-vs-Grade 3
7.805800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
7.689700E-02
Grade 1-vs-Grade 3
2.819800E-01
Grade 1-vs-Grade 4
8.620800E-01
Grade 2-vs-Grade 3
5.867800E-01
Grade 2-vs-Grade 4
7.515400E-01
Grade 3-vs-Grade 4
7.805800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.727200E-01
Normal-vs-NonDiabetic
7.882800E-01
Diabetic-vs-NonDiabetic
5.733800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.041600E-01
Normal-vs-NoPancreatitis
8.923200E-01
Pancreatitis-vs-NoPancreatitis
6.847000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.441400E-01
Normal-vs-N1
9.991600E-01
N0-vs-N1
5.368200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
7.104800E-01
Normal-vs-TP53-NonMutant
8.700400E-01
TP53-Mutant-vs-TP53-NonMutant
6.731800E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
